Eton Pharmaceuticals (ETON) Operating Expenses (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Operating Expenses data on file, last reported at $10.6 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses rose 81.91% year-over-year to $10.6 million; the trailing twelve-month figure through Dec 2025 stood at $43.6 million (up 67.58% YoY), and the FY2025 full-year result was $43.6 million, up 67.58% from the prior year.
• Operating Expenses climbed to $10.6 million in Q4 2025, from $9.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $13.4 million in Q2 2025 to a low of $4.4 million in Q4 2021.
• A 5-year average of $6.7 million and a median of $5.8 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses tumbled 44.31% in 2021 and surged 81.91% in 2025, its largest moves.
• Tracing ETON's Operating Expenses over 5 years: stood at $4.4 million in 2021, then increased by 20.22% to $5.3 million in 2022, then gained by 6.13% to $5.6 million in 2023, then advanced by 3.98% to $5.8 million in 2024, then surged by 81.91% to $10.6 million in 2025.
• Business Quant data shows ETON's Operating Expenses at $10.6 million in Q4 2025, $9.2 million in Q3 2025, and $13.4 million in Q2 2025.